Adamas Pharmaceuticals Inc entered the industry of in 2000 and has grown to employ 1 to 4 people, generating an annual revenue of $5.000.000 to $9.999.999. The NAICS classifies this business under the code 3254120, which describes it as a . For further clarification, the SIC classifies this business under the code 2834 and described it as a . The business provides service to the BOTH market.
To acquire more information, please contact Gregory Went, Chief Executive Officer by calling (510) 450-3500 during business hours. You can also write to the business’ Single Location at 2200 Powell St # 220, Emeryville, California CA 94608. You can also visit the company’s website at adamaspharma.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Adamas Pharmaceuticals Inc |
| Representative: | Gregory Went, Chief Executive Officer |
| Place of Business: | 2200 Powell St # 220, Emeryville, CA 94608 |
| Contact Number: | (510) 450-3500 |
| Website: | adamaspharma.com |
| Type of Service: | |
| SIC Number: | 2834 |
| NAICS Number: | 3254120 |
| Locality: | Single Location |
| Market Type: | B2B & B2C |
| Began: | 2000 |
| Income/Year: | $5.000.000 to $9.999.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Adamas Pharmaceuticals Inc is a company operating from Alameda, California providing professional and relevant BOTH variables. It was founded in 2000 and registered with the SIC code 2834 as , and with the NAICS code 3254120 as .
With a current employee count of 1 to 4, Adamas Pharmaceuticals Inc has gone to report making $5.000.000 to $9.999.999 per annum on its journey towards growth. This company invites you to contact its representative Gregory Went, Chief Executive Officer at (510) 450-3500 for related queries, or to locate its Single Location using the coordinates 37.83719,-122.301503.
The Single Location can also be found at the street address 2200 Powell St # 220 in Emeryville, California 94608 and can be engaged online through the company website at adamaspharma.com, the company Twitter , and Facebook page .